Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/150563
Author(s): Mariana Marques Antunes
Title: Characteristics and patient-reported outcomes of long-term lung cancer survivors
Issue Date: 2023-06-26
Abstract: Background: Due to advances in screening and treatment of lung cancer, there has been increased interest in long-term lung cancer survivors (LTLCS). The aim of this study was to evaluate the prevalence, characteristics and patient-reported outcomes (PROs) of LTLCS. Material and Methods: Cross-sectional study that included patients diagnosed with primary lung cancer between Jan/2012 and Dec/2016 whose overall survival was greater than 5 years. A self-administered questionnaire was applied, including EORTC QLQ-C30, PHQ-4 and two open questions regarding quality of life (QoL) and suggestions for improvements. Factors potentially related to QoL were analysed. Results: Of 767 lung cancer patients, 158 (20.6%) were LTLCS and LTLCS' proportion increased yearly. Most patients were diagnosed at early stages (66.2%) but 8.9% were at stage IV. During follow-up, 77.1% quitted smoking, 31.8% had disease progression/ relapse and 15.2% developed other tumours. Of all living LTLCS, 100 (85%) patients answered the PROs questionnaire. The median global health score was 66.67 [50-83], social function had the best score and emotional function the worst. Pain and fatigue were the symptoms with the worst impact on QoL. PHQ-4 identified mental distress in 36% and patients with a lower QoL were more likely to present anxiety (35.3% vs. 9.4%, p=0.007) or depression (27.9% vs. 3%, p=0.006). In the open questions, patients reported pain (17%), lack of familiar/financial support (16%), dyspnoea (14%), depression (8%), concern for the future (8%) and limitations performing daily activities (8%) as the aspects with most impact in QoL. The most suggested measures were improvement of care provided by health institutions (25%) and better social support (16%). Conclusion: Prevalence of LTLCS is increasing and survivors may experience a high prevalence of anxiety and depression as well as high disease burden affecting QoL. Therefore, it's important to provide a multidisciplinary continuous patient-centred care and a careful follow-up.
Description: Introdução: Os avanços no rastreio e no tratamento do cancro do pulmão aumentaram o interesse no estudo dos longos sobreviventes do cancro do pulmão (LSCP). O objetivo deste estudo foi avaliar a prevalência, características e patient-reported outcomes (PROs) dos LSCP. Materiais e métodos: Estudo transversal que incluiu os doentes de uma Unidade Multidisciplinar de Tumores Torácicos com cancro do pulmão diagnosticado entre Janeiro 2012 e Dezembro 2016, com sobrevivência global superior a 5 anos. Foi aplicado um questionário autoadministrado, que incluiu o EORTC QLQ-C30, o PHQ-4 e duas perguntas abertas relativas à qualidade de vida (QV) e sugestões de melhoria. Foram analisados fatores potencialmente relacionados com QV. Resultados: Dos 767 doentes com cancro do pulmão, 158 (20.6%) eram LSCP e a proporção de LSCP aumentou anualmente. A maioria dos doentes foi diagnosticada em estádios precoces (66.2%) mas 8.9% em estádio IV. Durante o follow-up, 77.1% deixaram de fumar, 31.8% tiveram progressão/recidiva de doença e 15.2% desenvolveram outros tumores. De todos os LSCP vivos, 100 (85%) responderam ao questionário de PROs. A mediana do score de saúde global foi 66.67 [50-83], o domínio social teve o melhor score e o emocional o pior. Dor e fadiga foram os sintomas mais impactantes na QV. O PHQ-4 identificou distúrbio mental em 36% dos doentes e os doentes com pior QV tinham mais frequentemente depressão (27.9% vs. 3%, p=0.006) ou ansiedade (35.3% vs. 9.4%, p=0.007). Nas perguntas abertas, os doentes referiram que dor (17%), falta de apoio familiar/financeiro (16%), dispneia (16%), depressão (8%), preocupação pelo futuro (8%) e limitações nas atividades de vida diárias (8%) eram os fatores com maior impacto na QV. As medidas mais sugeridas foram a melhoria dos cuidados prestados pelas instituições de saúde (25%) e maior apoio social (16%). Conclusão: A prevalência dos LSCP está a aumentar e estes doentes podem apresentar ansiedade, depressão, uma elevada carga de doença e aparecimento de novos tumores, o que pode afetar negativamente a QV. Assim, é importante oferecer uma abordagem multidisciplinar centrada no doente, continuada e com um seguimento cuidadoso.
Subject: Medicina clínica
Clinical medicine
Scientific areas: Ciências médicas e da saúde::Medicina clínica
Medical and Health sciences::Clinical medicine
DOI: 10.34626/magp-a355
URI: https://hdl.handle.net/10216/150563
Document Type: Dissertação
Rights: restrictedAccess
License: https://creativecommons.org/licenses/by-nc-nd/4.0/
Appears in Collections:FMUP - Dissertação

Files in This Item:
File Description SizeFormat 
632138.pdf
  Restricted Access
Characteristics and patient-reported outcomes of long-term lung cancer survivors4.16 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons